PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+26.96%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.73B
AUM Growth
+$1.73B
(-47%)
Cap. Flow
-$1.86B
Cap. Flow
% of AUM
-107.4%
Top 10 Holdings %
Top 10 Hldgs %
41.62%
Holding
92
New
18
Increased
6
Reduced
30
Closed
31
Top Buys
| 1 |
Biogen
BIIB
|
$67.8M |
| 2 |
Elevance Health
ELV
|
$60M |
| 3 |
Centene
CNC
|
$51.5M |
| 4 |
Pfizer
PFE
|
$36.2M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$31.7M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$135M |
| 2 |
Penumbra
PEN
|
$100M |
| 3 |
NXP Semiconductors
NXPI
|
$82.4M |
| 4 |
Zimmer Biomet
ZBH
|
$81.6M |
| 5 |
Microchip Technology
MCHP
|
$78.4M |
Sector Composition
| 1 | Healthcare | 84.24% |
| 2 | Technology | 3.36% |
| 3 | Consumer Discretionary | 0.65% |
| 4 | Financials | 0.12% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $116M | 5.55% | 1,076,442 -370,170 | -26% | -$40M |
|
2
Gilead Sciences
GILD
$140B
| $87.8M | 4.18% | 1,351,736 -492,124 | -27% | -$32M |
|
|
BOLD
3
DELISTED
Audentes Therapeutics, Inc
BOLD
| $73.8M | 3.51% | 1,232,873 -1,083,065 | -47% | -$64.8M |
|
|
4
Penumbra
PEN
$10.6B
| $68.8M | 3.28% | 418,792 -610,772 | -59% | -$100M |
|
|
NVRO
5
DELISTED
NEVRO CORP.
NVRO
| $67.8M | 3.23% | 577,163 +180,893 | +46% | +$21.3M |
|
|
6
Biogen
BIIB
$19.4B
| $67.8M | 3.23% | +228,328 | New | +$67.8M |
|
|
7
Zimmer Biomet
ZBH
$21B
| $66.3M | 3.16% | 442,627 -545,215 | -55% | -$81.6M |
|
|
8
Elevance Health
ELV
$71.8B
| $60M | 2.86% | +198,548 | New | +$60M |
|
|
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $58.3M | 2.78% | 2,413,464 +582,540 | +32% | +$14.1M |
|
10
Cigna
CI
$80.3B
| $54.3M | 2.59% | 265,717 -131,967 | -33% | -$27M |
|
|
AGN
11
DELISTED
Allergan plc
AGN
| $53.8M | 2.56% | 281,548 -174,050 | -38% | -$33.3M |
|
12
IQVIA
IQV
$32.4B
| $53.1M | 2.53% | 343,567 -133,435 | -28% | -$20.6M |
|
|
13
Centene
CNC
$14.3B
| $51.5M | 2.45% | +819,229 | New | +$51.5M |
|
|
ARNA
14
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $48.6M | 2.32% | 1,070,616 -1,200,920 | -53% | -$54.5M |
|
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $46.8M | 2.23% | 553,634 -1,595,417 | -74% | -$135M |
|
|
KRTX
16
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $45.4M | 2.16% | 602,551 +191,908 | +47% | +$14.5M |
|
17
HCA Healthcare
HCA
$94.5B
| $41.3M | 1.97% | 279,411 -137,322 | -33% | -$20.3M |
|
18
Novartis
NVS
$245B
| $40.7M | 1.94% | 442,640 -246,960 | -36% | -$22.7M |
|
|
19
Pfizer
PFE
$141B
| $36.2M | 1.72% | +923,126 | New | +$36.2M |
|
|
DERM
20
DELISTED
Dermira, Inc.
DERM
| $34.4M | 1.64% | 2,271,180 -1,558,356 | -41% | -$23.6M |
|
21
Icon
ICLR
$13.8B
| $33.3M | 1.59% | 193,577 -43,598 | -18% | -$7.51M |
|
|
IMMU
22
DELISTED
Immunomedics Inc
IMMU
| $31.7M | 1.51% | +1,499,239 | New | +$31.7M |
|
23
iRhythm Technologies
IRTC
$5.46B
| $31.2M | 1.49% | 458,241 -622,818 | -58% | -$42.4M |
|
24
ICU Medical
ICUI
$3.15B
| $31M | 1.48% | +165,665 | New | +$31M |
|
25
Humana
HUM
$36.5B
| $29.2M | 1.39% | +79,546 | New | +$29.2M |
|